Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study-MedSci.cn

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

Elkrief, A; Alessi, JMV; Ricciuti, B; Brown, S; Rizvi, H; Preeshagul, IR; Wang, XA; Pecci, F; Di Federico, A; Lamberti, G; Egger, JV; Chaft, JE; Rudin, CM; Riely, GJ; Kris, MG; Ladanyi, M; Chen, Y; Hellmann, MD; Shen, RL; Awad, MM; Schoenfeld, AJ

Schoenfeld, AJ (通讯作者)，Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA.;Schoenfeld, AJ (通讯作者)，Weill Cornell Med Coll, New York, NY 10065 USA.

Abstract

BackgroundSingle-agent PD-(L)1 blockade (IO) alone or in combination with chemotherapy (Chemotherapy-IO) is approved first-line therapies in patients ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

科室

工具

服务